These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. C-peptide during the prolonged fast in insulinoma. Service FJ, O'Brien PC, McMahon MM, Kao PC. J Clin Endocrinol Metab; 1993 Mar; 76(3):655-9. PubMed ID: 8445021 [Abstract] [Full Text] [Related]
4. Diagnosis of insulinoma using the ratios of serum concentrations of insulin and C-peptide to glucose during a 5-hour oral glucose tolerance test. Li X, Zhang F, Chen H, Yu H, Zhou J, Li M, Li Q, Li L, Yin J, Liu F, Bao Y, Han J, Jia W. Endocr J; 2017 Jan 30; 64(1):49-57. PubMed ID: 27725372 [Abstract] [Full Text] [Related]
5. Combined use of calcium infusion localization and a minimally invasive surgical procedure in the management of insulinoma. Reynolds LR, Park AE, Miller RE, Karounos DG. Endocr Pract; 2002 Jan 30; 8(5):329-34. PubMed ID: 15251834 [Abstract] [Full Text] [Related]
7. Using the Secretion Ratios of Insulin and C-peptide During the 2-h Oral Glucose Tolerance Test to Diagnose Insulinoma. Liao J, Ding F, Luo W, Nie X, He Y, Li G. Dig Dis Sci; 2021 May 30; 66(5):1533-1539. PubMed ID: 32529519 [Abstract] [Full Text] [Related]
9. Anomalous glucose and insulin responses in patients with insulinoma. Caveats for diagnosis. Dons RF, Hodge J, Ginsberg BH, Brennan MF, Cryer PE, Kourides IA, Gorden P. Arch Intern Med; 1985 Oct 30; 145(10):1861-3. PubMed ID: 2994586 [Abstract] [Full Text] [Related]
10. Comparison of the diagnostic accuracy of the current guidelines for detecting insulinoma. Dauben L, Simon MC, Strassburger K, Burkart V, Weber KS, Schinner S, Roden M, Müssig K. Eur J Endocrinol; 2019 Jun 01; 180(6):381-386. PubMed ID: 30991361 [Abstract] [Full Text] [Related]
11. Presentation, diagnostic features and glucose handling in a monocentric series of insulinomas. Toaiari M, Davì MV, Dalle Carbonare L, Boninsegna L, Castellani C, Falconi M, Francia G. J Endocrinol Invest; 2013 Oct 01; 36(9):753-8. PubMed ID: 23608735 [Abstract] [Full Text] [Related]
12. Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma. Ueda K, Kawabe K, Lee L, Tachibana Y, Fujimori N, Igarashi H, Oda Y, Jensen RT, Takayanagi R, Ito T. Pancreas; 2017 Apr 01; 46(4):476-481. PubMed ID: 28230660 [Abstract] [Full Text] [Related]
13. Case report: a glucose responsive insulinoma--implication for the diagnosis of insulin secreting tumors. Sjoberg RJ, Kidd GS. Am J Med Sci; 1992 Sep 01; 304(3):164-7. PubMed ID: 1476155 [Abstract] [Full Text] [Related]
17. Modified hyperinsulinaemic, eu- and hypoglycaemic clamp technique using lispro-insulin for insulinoma diagnostic. Roudovitch N, Nauck MA, Schatz H, Pfeiffer AF. Exp Clin Endocrinol Diabetes; 2001 Jul 01; 109(8):397-401. PubMed ID: 11748487 [Abstract] [Full Text] [Related]
18. [Missed hyperinsulinaemia in a patient with an insulinoma]. Wouters RS, van den Ouweland JM, Pouwels JG, Wolffenbuttel BH. Ned Tijdschr Geneeskd; 2005 Apr 23; 149(17):944-6. PubMed ID: 15884409 [Abstract] [Full Text] [Related]
19. Diagnostic interpretation of the intravenous tolbutamide test for insulinoma. McMahon MM, O'Brien PC, Service FJ. Mayo Clin Proc; 1989 Dec 23; 64(12):1481-8. PubMed ID: 2557494 [Abstract] [Full Text] [Related]